Fexofenadine effects on cognitive performance in aviators at ground level and simulated altitude

Aviation Space and Environmental Medicine

Volumn 79, Issue 8, 2008, Pages 754-760

  Vacchiano, Charles ^a,b,c   Moore, Jeffrey ^a,d   Rice, George M ^a,b   Crawley, Gary ^a  

^a Naval Aerospace Medical Research Laboratory   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

^d Naval Hospital ^*

Author keywords

Altitude; Antihistamines; Attention; Cognitive performance; Hypoxia; Vigilance

Indexed keywords

CETIRIZINE; FEXOFENADINE; PLACEBO;

ADULT; AEROMEDICAL VIGILANCE TEST; AIRPLANE CREW; ALERTNESS; ALTITUDE; ANALYTICAL ERROR; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DROWSINESS; DRUG EFFECT; ENVIRONMENTAL TEMPERATURE; FEMALE; HUMAN; HYPOXIA; MALE; MENTAL TEST; NORMAL HUMAN; OXYGEN TENSION; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SKILL; VISUAL ANALOG SCALE;

ADULT; AEROSPACE MEDICINE; ALTITUDE; ANTI-ALLERGIC AGENTS; ATTENTION; CETIRIZINE; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PLACEBOS; REACTION TIME; SLEEP STAGES; TERFENADINE;

EID: 48649109678     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.2212.2008     Document Type: Article

References (24)

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(5, Suppl.)S147-334.
2. Bower EA, Moore JL, Moss M, Selby KA, Austin M, Meeves S. The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel. Aviat Space Environ Med 2003; 74:145-52.
3. Brandl H, Lachenmayr B. Dependence of the sensitivity of the central visual field on hemoglobin-oxygen saturation. Ophthalmologe 1994; 91:151-5.
4. Connolly DM, Hosking SL. Aviation-related respiratory gas disturbances affect dark adaptation: a reappraisal. Vision Res 2006; 46:1784-93.
5. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000; 6:373-8.
6. Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998; 81(5, Pt. 2):478-518.
7. Ernsting J. Mild hypoxia and the use of oxygen in flight. Aviat Space Environ Med 1984; 55:407-10.
8. Gengo FM. Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: strategies and progress. J Allergy Clin Immunol 1996; 98(6, Pt. 3):S319-25.
9. Gold RE, Kulak LL. Effect of hypoxia on aircraft pilot performance. Aerosp Med 1972; 43:180-3.
10. Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy 1999; 29(Suppl. 3):133-42.
11. Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy 2002; 32:133-9.
12. Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol 1999; 104:927-33.
13. Li XY, Wu XY, Fu C, Shen XF, Yang CB, Wu YH. Effects of acute exposure to mild or moderate hypoxia on human psychomotor performance and visual-reaction time. Space Med Med Eng (Beijing) 2000; 13:235-9.
14. Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, et al. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996; 76:448-54.
15. Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with "non- sedating" antihistamines: four prescription-event monitoring studies in general practice. BMJ 2000; 320:1184-6.
16. Martin RL, Watson DB, Smith SE, McAnally KI, Emonson DL. Effect of normobaric hypoxia on sound localization. Aviat Space Environ Med 2000; 71:991-5.
17. Meltzer EO, Weiler JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:617-26.
18. Nicholson AN, Stone BM, Turner C, Mills SL. Antihistamines and aircrew: usefulness of fexofenadine. Aviat Space Environ Med 2000; 71:2-6.
19. Nicholson AN, Turner C. Central effects of the H1-antihistamine, cetirizine. Aviat Space Environ Med 1998; 69:166-71.
20. Ramaekers JG, Uiterwijk MM, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol 1992; 42:363-9.
21. Shamsi Z, Kimber S, Hindmarch I. An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 2001; 56:865-71.
22. U.S. Department of Health and Human Services. Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis. Rockville, MD: Agency for Healthcare Research and Quality; 2002. Summary, Evidence Report/Technology Assessment: Number 54.
23. van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000; 55:116-34.
24. Weiler JM, Bloomfield JR, Woodworth GG, Grant AR, Layton TA, Brown TL, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med 2000; 132:354-63.